Third Wave Shareholders Tender 92 Percent of Shares to Hologic

Jul 17, 2008

NEW YORK (GenomeWeb News) – Hologic said today that Third Wave Technologies' shareholders have tendered approximately 45,225,950 shares, or around 92.1 percent of the company’s outstanding stock, as of the close of its initial offering period to acquire Third Wave, which expired last night.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Breaking News

The Scan

Privacy Policy Information, Please

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

Moving the Parts About

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

This Week in Science

In Science this week: genetic overlap among many psychiatric disorders, and more.

Just Skip that Step

The Economist writes that an increasing number of scientific journals don't do peer review.

Main menu